News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Hemispherx Biopharma (HEB) Announces Financial Results for the Three Months Ended September 30, 2012


11/5/2012 9:38:05 AM

PHILADELPHIA, Nov. 2, 2012 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE:HEB) announced its financial results for the three months ended September 30, 2012. The net comprehensive loss for the period (including non-cash effects of the redeemable warrants valuation adjustment) was approximately $6,425,000 or $(0.04) per share as compared to a net comprehensive loss of approximately $3,269,000 or ($0.02) per share for the same period in 2011.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES